Nexien BioPharma, Inc.
General ticker "NXEN" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $667.8K (TTM average)
Nexien BioPharma, Inc. does not follow the US Stock Market performance with the rate: -18.9%.
Estimated limits based on current volatility of 27.1%: low -0.00$, high 0.00$
Factors to consider:
- Total employees count: 3 as of 2018
- Top business risk factors: Going concern, Conflicts of interest, Drug development risks, Market acceptance, Strategic risks and growth management
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-06-30 to 2026-06-30
- 2024-06-30 to 2025-06-30 estimated range: [0.01$, 0.03$]
- 2025-06-30 to 2026-06-30 estimated range: [0.01$, 0.03$]
Financial Metrics affecting the NXEN estimates:
- Positive: with PPE of -5.2 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -5.11 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Positive: Interest expense per share per price, % of 2.80 <= 3.41
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of -8622.48 <= 18.93
- Negative: negative Industry operating income (median)
Short-term NXEN quotes
Long-term NXEN plot with estimates
Financial data
| YTD | 2022-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $0.34MM | $0.36MM | $0.24MM |
| Operating Income | $-0.34MM | $-0.36MM | $-0.24MM |
| Non-Operating Income | $-0.29MM | $0.00MM | $0.00MM |
| Interest Expense | $0.06MM | $0.03MM | $0.04MM |
| Income(Loss) | $-0.63MM | $-0.36MM | $-0.24MM |
| Profit(Loss)* | $-0.63MM | $-0.36MM | $-0.24MM |
| Stockholders Equity | $-0.12MM | $-0.25MM | $-0.36MM |
| Assets | $0.12MM | $0.04MM | $0.00MM |
| Operating Cash Flow | $-0.08MM | $-0.08MM | $-0.06MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $0.17MM | $0.00MM | $0.03MM |
| Earnings Per Share** | $-0.01 | $-0.01 | $-0.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.